APA citiranje

Cuyàs, E., Pérez-Sánchez, A., Micol, V., Menendez, J. A., & Bosch-Barrera, J. (2016). STAT3-targeted treatment with silibinin overcomes the acquired resistance to crizotinib in ALK-rearranged lung cancer. Cell Cycle.

Citação norma Chicago

Cuyàs, Elisabet, Almudena Pérez-Sánchez, Vicente Micol, Javier A. Menendez, and Joaquim Bosch-Barrera. "STAT3-targeted Treatment With Silibinin Overcomes the Acquired Resistance to Crizotinib in ALK-rearranged Lung Cancer." Cell Cycle 2016.

MLA citiranje

Cuyàs, Elisabet, et al. "STAT3-targeted Treatment With Silibinin Overcomes the Acquired Resistance to Crizotinib in ALK-rearranged Lung Cancer." Cell Cycle 2016.